Open original FDA record ↗Recall record
- FDA identifier
- Z-0306-2021
- Company in FDA record
- GE Healthcare, LLC
- FDA record creation date
- Oct 29, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a potential for a smudge artifact that could be suspect for pathology in some images due to incorrect settings.
Source facts
- Action
- The recall strategy outlined below addresses the depth of the recall and recall notification (customer letter) effectiveness check. This issue will be resolved by sending an Urgent Medical Device Correction letter (attached) to customers with potentially affected systems. This letter will inform the customer of the issue and provide safety instructions for continued use. GE Healthcare will inspect potentially affected systems and correct, if needed. In the U.S., this letter will be sent by a traceable means. This letter will be sent to the following titles within the affected accounts: Director of Clinical/Radiology, Risk Manager/Hospital Administrator, Director of Biomedical Engineering. GE Healthcare will document customer acknowledgment of the receipt and understanding of the letter, and the inspection and correction, if needed, of potentially affected systems. Records will be retained per our processes and procedures.
- Initiated
- 2020-09-21
- Root cause
- Device Design
- Terminated
- 2022-12-28
- Distribution
- Worldwide distribution - US Nationwide distribution including in the states of FL, GA, IL, MI, NC, NE, NJ, PA, TX, VA, WA, and WI. The countries of Australia, Austria, Belgium, Canada, China, Denmark, Estonia, Finland, France, Japan, Kuwait, Norway, Saudi Arabia, Spain, Sweden, Switzerland, Thailand, and United Kingdom.
- Recall number
- Z-0306-2021
- Recall status
- Terminated
- CDRH record ID
- 184001
- FDA record created
- 2020-10-29
- Recall event number
- 86544